Back to Trades
Buy4
CARLSMED, INC.
CARL
Total Value
$20.0M
Net $20.0M bought
Purchases
$20.0M
1 transaction
Company Information
- Company Name
- CARLSMED, INC.
- Ticker Symbol
- CARL
- CIK
- 0001794546
Insider Information
- Role
- Insider
- Location
- MANHATTAN BEACH, CA
Filing Details
- Filing Date
- Jul 24, 2025
- Transaction Date
- Jul 24, 2025
- Accession Number
- 0000950170-25-098549
- Form Type
- 4
- Net Trading Amount
- $20.0M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 24, 2025 | Common Stock | 3,680,506 | — | C | — |
| Jul 24, 2025 | Common Stock | 1,333,333 | $15.00 | Purchase | $20.0M |
| Jul 24, 2025 | Common Stock | 2,376,472 | — | C | — |
| Jul 24, 2025 | Common Stock | 931,452 | — | C | — |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jul 24, 2025 | Derivative | 1,445,020 | — | C | — |
| Jul 24, 2025 | Derivative | 2,235,486 | — | C | — |
| Jul 24, 2025 | Derivative | 1,445,020 | — | C | — |
| Jul 24, 2025 | Derivative | 931,452 | — | C | — |
| Jul 24, 2025 | Derivative | 931,452 | — | C | — |
Footnotes
- (F1)Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock (collectively, the "Preferred Stock") automatically converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering without payment of additional consideration. The Preferred Stock had no expiration date.
- (F2)Shares held by B Capital Global Growth III, L.P.
- (F3)Shares held by B Capital Healthcare I, L.P.
- (F4)Shares held by Hornet Co-Invest, L.P.
- (F5)B Capital Group Management, LP is the manager of B Capital Global Growth III, L.P. and B Capital Healthcare I, L.P. Hornet-Co-Invest Investors, Ltd. is the ultimate general partner of Hornet Co-Invest, L.P. (Hornet Co-Invest, L.P., together with B Capital Healthcare I, L.P., and B Capital Global Growth III, L.P., "B Capital"). Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Exchange Act, except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.